Impregnated central venous catheters reduce CLABSI



BACKGROUND: The objective of this study was to compare the incidence of catheter-related bloodstream infection (CRBSI) with the use of second-generation chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters, rifampicin-miconazole (RM)-impregnated catheters, and standard catheters.

METHODS: Retrospective study of patients admitted to an intensive care unit who received CHSS, RM, or standard catheters in femoral venous access.

RESULTS: We diagnosed 18 CRBSIs in 245 patients with standard catheters in 2,061 days, zero CRBSI in 169 patients with CHSS-impregnated catheters in 1,489 days, and zero CRBSI in 227 patients with RM-impregnated catheters in 2,009 days. Patients with standard catheters compared with CHSS- and RM-impregnated catheters showed a higher rate of CRBSI (7.3%, 0%, and 0%, respectively; P < .001) and higher incidence density of CRBSI (8.7, 0, and 0 per 1,000 catheter days, respectively; P < .001). We found in the exact Poisson regression that standard catheters were associated with a higher CRBSI incidence than CHSS-impregnated catheters (P < .001) and RM-impregnated catheters (P < .001), controlling for catheter duration. We found in survival analysis that standard catheters were associated with a lower CRBSI-free time than CHSS-impregnated catheters (P < .001) and RM-impregnated catheters (P < .001).

CONCLUSION: We found that CHSS- and RM-impregnated catheters decreased similarly the risk of CRBSI.


Lorente, L., Lecuona, M., Jiménez, A., Raja, L., Cabrera, J., Gonzalez, O., Diosdado, S., Marca, L. and Mora, M.L. (2015) Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. American Journal of Infection Control. September 24th. .

Thank you to our partners for supporting IVTEAM


Comments are closed.